Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
149
pubmed:dateCreated
2010-11-24
pubmed:abstractText
Among transplant recipients, those who produce antibodies against the donor's human leukocyte antigens (HLAs) are at higher risk for antibody-mediated rejection and transplant vasculopathy, which is a progressive, vasculo-occlusive disease that results in ischemic injury and deterioration of organ function. Antibodies against HLA class I (HLA-I) molecules are thought to contribute to transplant vasculopathy by triggering signals that elicit the activation and proliferation of endothelial cells. Here, we demonstrate a molecular association between HLA-I and the integrin ?(4) subunit after the stimulation of endothelial cells with HLA-I-specific antibodies. Knockdown of integrin ?(4) in these cells abrogated the ability of HLA-I to stimulate the phosphorylation of the kinases Akt, extracellular signal-regulated kinase (ERK), and Src, as well as cellular proliferation. Similarly, reducing the abundance of HLA-I suppressed integrin ?(4)-mediated phosphorylation of ERK and the migration of endothelial cells on laminin-5, a component of the extracellular matrix. These results indicate a mutual dependency between HLA-I and the integrin ?(4) subunit to stimulate the proliferation and migration of endothelial cells, which may be important in promoting transplant vasculopathy and tumor angiogenesis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1937-9145
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
ra85
pubmed:meshHeading
pubmed-meshheading:21098729-Analysis of Variance, pubmed-meshheading:21098729-Animals, pubmed-meshheading:21098729-Blotting, Western, pubmed-meshheading:21098729-Cell Adhesion Molecules, pubmed-meshheading:21098729-Cell Line, pubmed-meshheading:21098729-Cell Movement, pubmed-meshheading:21098729-Cell Proliferation, pubmed-meshheading:21098729-Endothelial Cells, pubmed-meshheading:21098729-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:21098729-Gene Knockdown Techniques, pubmed-meshheading:21098729-Histocompatibility Antigens Class I, pubmed-meshheading:21098729-Humans, pubmed-meshheading:21098729-Immunoprecipitation, pubmed-meshheading:21098729-Integrin beta4, pubmed-meshheading:21098729-Mice, pubmed-meshheading:21098729-Microscopy, Confocal, pubmed-meshheading:21098729-Oncogene Protein v-akt, pubmed-meshheading:21098729-Phosphorylation, pubmed-meshheading:21098729-RNA, Small Interfering, pubmed-meshheading:21098729-Signal Transduction, pubmed-meshheading:21098729-Transfection, pubmed-meshheading:21098729-Wound Healing, pubmed-meshheading:21098729-src-Family Kinases
pubmed:year
2010
pubmed:articleTitle
HLA class I molecules partner with integrin ?4 to stimulate endothelial cell proliferation and migration.
pubmed:affiliation
Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural